glp-1 podcast Drugs - One Thing They Don't Reduce [Podcast] Oprah Winfrey reveals taking GLP-1

Heres what the research and my clinical experience reveal: Semaglutide is a well-established option with: Weekly injections Proven safety profile Average weight loss of 15-20% of body weight Effective appetite suppression Improvements in cardiovascular health markers Tirzepatide offers: Weekly injections Potentially greater weight loss (16-22.5% of body weight) Dual-action mechanism Similar side effect profile to semaglutide Enhanced metabolic benefits In a recent head-to-head trial , tirzepatide demonstrated superior weight loss compared to semaglutide, with participants losing an average of 20.2% versus 13.7% of their body weight at 72 weeks

Theranostics 14(8):33393357

Laboratory studies investigate how senescent microglia and astrocytes contribute to neuroinflammation and disease progression in neurodegenerative disease models, while FOXO4-DRI provides researchers with tools for testing whether senescent cell elimination can restore brain function and reduce neuroinflammatory markers

This is the time when the gastrointestinal side effects of these agents, namely nausea, anorexia and some vomiting, are most evident